This is the authors' abstract. We don't add key points for this paper.
Engineering sesquiterpene synthases to form predefined alternative products is a major challenge due to their diversity in cyclisation mechanisms and our limited understanding of how amino acid changes affect the steering of these mechanisms. Here, we use a combination of atomistic simulation and site-directed mutagenesis to engineer a selina-4(15),7(11)-diene synthase (SdS) such that its final reactive carbocation is quenched by a trapped active site water, resulting in the formation of a complex hydroxylated sesquiterpene (selina-4-ol). Initially, the SdS G305E variant produced 20% selina-4-ol. As suggested by modelling of the enzyme-carbocation complex, selina-4-ol production could be further improved by varying the pH, resulting in selina-4-ol becoming the major product (48%) at pH 6.0. We incorporated the SdS G305E variant along with genes from the mevalonate pathway into bacterial BL21(DE3) cells and demonstrated production of selina-4-ol at a scale of 10 mg/L in batch fermentation. These results highlight opportunities for simulation-guided engineering of terpene synthases to produce predefined complex hydroxylated sesquiterpenes.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Srivastava et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: